Correlation of NT-proBNP, proANP and novel biomarkers: Copeptin and proadrenomedullin with LVEF and NYHA in patients with ischemic CHF, non-ischemic CHF and arterial hypertension

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F11%3A00003342" target="_blank" >RIV/00216208:11120/11:00003342 - isvavai.cz</a>
Alternative codes found
RIV/00064173:_____/11:#0000066
Result on the web
<a href="http://dx.doi.org/10.1016/j.ijcard.2011.05.029" target="_blank" >http://dx.doi.org/10.1016/j.ijcard.2011.05.029</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ijcard.2011.05.029" target="_blank" >10.1016/j.ijcard.2011.05.029</a>

Result language
angličtina
Original language name
Correlation of NT-proBNP, proANP and novel biomarkers: Copeptin and proadrenomedullin with LVEF and NYHA in patients with ischemic CHF, non-ischemic CHF and arterial hypertension
Original language description
Novel biomarkers contributing to heart failure pathophysiology included copeptin and proadrenomedullin have additional prognostic information when assessed together with natriuretic peptides. The purpose of the present study was to assess correlation ofcopeptin (COP), adrenomedullin (proADM), proBNP and proANP with NYHA class, LVEF and other parameters in CHF patients with ischemic and non-ischemic cardiomyopathy and subjects with arterial hypertension followed at tertiary care heart function clinic.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)